Download as pdf or txt
Download as pdf or txt
You are on page 1of 2

Clinical SnaDshot

Neonatal Hemangiomatosis
Laura Yousenasna

Figure 1.
The ''Clinical Snapshot" series provides a concise These red papules and nodules range in size from
examination of a clinical presentation including pinpoint to 1 cm.
history, treatment, patient education, and nursing
measures. Using the format here, you are invited to
submit your "Clinical Snapshot" to Dermatology
Nursing.

Description of Skin Lesion: Multiple heman-


giomas are scattered in a generalized distribution in a 1-
month old infant. These red papules and nodules range
in size from pinpoint to I cm (see Figure 1).
Location: Hemangiomatosis, defined as multiple
(typically five or more) hemangiomas, presents with
small cutaneous hemangiomas that may occur anywhere
on the skin or mucous membranes. In addition to cuta-
neous lesions, hemangiomatosis may involve visceral
organs, including, but not limited to, the liver, gastroin-
testinal tract, and brain. ally round papules and nodules, while segmental
hemangiomas are typically plaque-like and seem to
Normal Course: As with traditional hemangiomas,
cover a region or territory of skin. Hemangiomas associ-
these hemangiomas may appear any time from birth ated with hemagiomatosis are typically small (pinpoint
through the first few months of life. Normally heman- to 1 cm) in size and localized.
giomas proliferate for an average of fi months to 1 year,
after which time they slowly regress (involute) over a Treatment: No treatment is needed for uncomplicat-
ed lesions as all hemangiomas will show some degree of
number of years. However, the small hemangiomas of
improvement, and often completely resolve, over time.
hemangiomatosis often do not show significant growth Systemic corticosteroids are generallyfirst-linetherapy for
and involute rapidly, sometimes within the first year. patients at risk for complications such as visual obstruc-
Although the vast majority of infants with heman- tion, cardiac failure, or respiratory compromise. A (i to 8
giomatosis have no complications, infants with signifi- week course of oral steroids followed by a gradual taper is
cant visceral involvement can rarely develop serious generally used during the growth phase.
complications. Cardiac failure may occur due to arterio-
Patient Education: The diagnosis, prognosis, and
venous shunting in patients with diffuse hepatic heman-
treatment expectations should be discussed with parents.
giomas. Gastrointestinal hemorrhage, neurologic seque- Many families are relieved to know that most heman-
lae, and other complications are also possible with vis- giomas resolve without complications, but the slow
ceral involvement, depending on location. regression of hemangiomas should be emphasized.
Etiology: The cause of hemangiomatosis is Proper tapering of oral steroids and side effects of med-
unknown, but hemangiomas overall occur more fre- ications should be discussed with parents of infants
quently in female, Caucasian infants. Multiple heman- receiving treatment.
giomas are also strongly associated with prematurity and
Nursing Measures: Infants less than fj months of
multiple births, and occur more frequently in infants age with five or more cutaneous hemangiomas should
whose mothers had placenta previa or preeclampsia be evaluated for possible visceral involvement.
during pregnancy. Abdominal and head ultrasounds are appropriate
Hallmark of Disease: Traditional hemangiomas screening tools. Prompt recognition of cutaneous
can occur in various sizes ranging from pinpoint to cov- hemangiomas can lead to early diagnosis of visceral
ering an entire body segment and are subcategodzed as involvement. While most patients diagnosed with vis-
localized or segmental. Localized hemangiomas are usu- ceral involvement remain healthy, a small subset can
develop serious complications during the growth phase,
Laura Yousenasna, BSN, RN, is a Staff Nurse, Dermatology
so monitoring is key, with intervention dependent on
Clinic, Texas Children's Hospital, Houston, TX. the patient's clinical status. •

86 DERMATOLOGY NURSING/February 2007/Voi. 19/NQ. 1

You might also like